S. Cheng

发表

Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with Candida albicans Infection

S. Jiang, W. Chiang, D. Hwang, 2022, International journal of molecular sciences.

BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells

M. Coumar, Pai-Sheng Chen, Sailu Sarvagalla, 2019, Autophagy.

PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan

F. Hildebrandt, E. Otto, Shang-Jyh Hwang, 2022, npj Genomic Medicine.

The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells.

Sree Karani Kondapuram, M. Coumar, Yi-Chen Lin, 2020, Toxicology and applied pharmacology.

SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma

Ch Lai, Pei-I Chi, D. Hwang, 2022, Journal of experimental & clinical cancer research : CR.

Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation

W. Chung, D. Hwang, L. Lim, 2022, Journal of translational medicine.

Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE

C. Cheung, E. Leung, S. Cheng, 2020, Journal of Biomedical Science.

Survivin – biology and potential as a therapeutic target in oncology

F. Tsai, Jang-Yang Chang, C. Cheung, 2013, OncoTargets and therapy.

HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells

U. Kikkawa, Chih-Yang Wang, Wen-Chang Chang, 2022, Journal of Experimental & Clinical Cancer Research.

The “Dark Side” of autophagy on the maintenance of genome stability: Does it really exist during excessive activation?

C. Cheung, S. Cheng, Tzu-Yu Lin, 2021, Journal of cellular physiology.

YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair.

C. Cheung, E. Leung, S. Cheng, 2021, Pharmacological research.

HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells

Kuo-Ting Lee, Y. Kuo, C. Chuang, 2017, Front. Pharmacol..

Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study

C. Cheung, Ju-Ya Tsai, S. Cheng, 2016, OncoTargets and therapy.

Polycythemia Secondary to Renal Hemangioblastoma: A Case Report and Literature Review.

D. Hwang, Y. Chiu, S. Cheng, 2023, International journal of surgical pathology.

Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells

Chien-Feng Li, Yi-Ching Wang, J. Kanwar, 2016, Front. Pharmacol..

Survivin – biology and potential as a therapeutic target in oncology

F. Tsai, Jang-Yang Chang, C. Cheung, 2013, OncoTargets and therapy.

Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan

N. Chiang, S. Cheng, Ying-Jui Chao, 2024, Journal of biomedical science.